| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Bigi R | |
| P2860 | cites work | Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging | Q28334566 |
| Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallium-201 myocardial perfusion imaging | Q28335555 | ||
| National survey of exercise stress testing facilities | Q34057350 | ||
| Exercise standards. A statement for health professionals from the American Heart Association | Q37994466 | ||
| Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients | Q39492922 | ||
| Frequency of life-threatening complications associated with exercise testing (author's transl) | Q41732870 | ||
| Cardiac Arrest during Dipyridamole Imaging | Q42213709 | ||
| Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging | Q42220155 | ||
| Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study | Q42545776 | ||
| Incidence and correlates of complex ventricular arrhythmias during dobutamine stress echocardiography after acute myocardial infarction | Q42555673 | ||
| Death with dipyridamole-thallium imaging | Q42668193 | ||
| Acute pulmonary edema caused by prolonged myocardial stunning after dipyridamole-thallium imaging | Q45195476 | ||
| Diagnosis of ischemic heart disease with adenosine echocardiography | Q48591746 | ||
| Stress echocardiography and the human factor: the importance of being expert. | Q52237641 | ||
| Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. | Q52380491 | ||
| Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests | Q52999393 | ||
| Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. | Q53380668 | ||
| Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. | Q53394079 | ||
| Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography | Q67719991 | ||
| Safety and characteristics of exercise testing early after acute myocardial infarction | Q69594721 | ||
| High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: correlation with exercise testing and coronary angiography | Q69666858 | ||
| [Value of the dipyridamole test in the diagnosis of coronary heart disease. Comparison with the stress ECG and coronary angiogram] | Q70993645 | ||
| Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia | Q71388071 | ||
| Dobutamine stress echocardiography for the identification of multivessel coronary artery disease after uncomplicated myocardial infarction: the importance of test end-point | Q71740710 | ||
| Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging | Q71820721 | ||
| Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value | Q72194255 | ||
| Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography | Q72564298 | ||
| P433 | issue | 10 | |
| P921 | main subject | echocardiography | Q216933 |
| stress echocardiography | Q3577490 | ||
| P304 | page(s) | 776-780 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Complications of pharmacologic stress echocardiography in coronary artery disease | |
| P478 | volume | 19 |
Search more.